|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development, including stock-based compensation of $1,027, $933 and $655, respectively | |||||
| General and administrative, including stock-based compensation of $2,845, $2,261 and $1,921, respectively | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (expense) income: | |||||
| Interest income | |||||
| Other expense | |||||
| Change in fair value of warrant liabilities | |||||
| Total other (expense) income, net | |||||
| Net loss | |||||
| Net loss per share of common stock, basic and diluted | |||||
| Basic and diluted weighted average shares outstanding | |||||
| Basic net loss per share | |||||
| Shares used in computing basic net loss per share | |||||
| Diluted net loss per share | |||||
| Shares used in computing diluted net loss per share |
Loading...
